title: Phorbol 12,13-dibutyrate and mitogens increase fructose 2,6-bisphosphate in lymphocytes. Comparison of lymphocyte and rat-liver 6-phosphofructo-2-kinase.
abstract: The influence of tumour promoters and growth factors on glycolysis and on fructose-2,6-bisphosphate concentration was studied in isolated mouse spleen lymphocytes and in purified B-cells. The intracellular concentration of fructose 2,6-bisphosphate and the rate of lactate release were increased 2-3-fold in spleen lymphocytes exposed to active phorbol esters, mitogenic lectins, interleukin 4 or lipopolysaccharide. The maximal effect was observed after 1 h of exposure. In these cells hexose 6-phosphates increased 2-fold and 6-phosphofructo-2-kinase activity remained unchanged after treatment with phorbol 12,13-dibutyrate or with lectins. Exposure of B-cells to phorbol 12,13-dibutyrate, interleukin 4 or lipopolysaccharide increased the glycolytic flux and the concentration of fructose 2,6-bisphosphate without relation to their mitogenic activity. Lymphocytes and rat liver 6-phosphofructo-2-kinase were partially purified using the same procedure. The lymphocyte enzyme was not inhibited by sn-glycerol 3-phosphate in contrast to the potent inhibition observed in liver. Treatment of both enzymes with the catalytic subunit of the cyclic-AMP-dependent protein kinase failed to inactivate 6-phosphofructo-2-kinase from lymphocytes. These differences suggest that lymphocytes and liver contain different forms of this enzyme.
authors.affiliation: Instituto de Bioquímica, Facultad de Farmacia, Madrid, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Bosca
authors.forename: M
authors.initials: M
authors.lastname: Mojena
authors.forename: J M
authors.initials: JM
authors.lastname: Diaz-Guerra
authors.forename: C
authors.initials: C
authors.lastname: Marquez
mesh_terms: D000818:Animals; D001402:B-Lymphocytes / Q000201:enzymology; D003208:Concanavalin A / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D005635:Fructosediphosphates / Q000378:metabolism*; D006598:Hexosediphosphates / Q000378:metabolism*; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D008070:Lipopolysaccharides / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008934:Mitogens / Q000494:pharmacology*; D009928:Organ Specificity; D015240:Phorbol 12,13-Dibutyrate; D010703:Phorbol Esters / Q000494:pharmacology*; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D051381:Rats; D013154:Spleen / Q000201:enzymology
chemical_list: D005635:Fructosediphosphates; D006598:Hexosediphosphates; D007773:Lactates; D008070:Lipopolysaccharides; D008934:Mitogens; D010703:Phorbol Esters; D003208:Concanavalin A; D015240:Phorbol 12,13-Dibutyrate; C027652:fructose 2,6-diphosphate; D010732:Phosphofructokinase-1